Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience. - Test2 - elhamkhani - TriplyDB

Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience.

Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience.

http://www.wikidata.org/entity/Q38191615

about

Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.Optimal management of primary focal segmental glomerulosclerosis in adults Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome.Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.Steroid-resistant nephrotic syndrome: past and current perspectives.Immunosuppressive therapy for steroid-resistant nephrotic syndrome: a Bayesian network meta-analysis of randomized controlled studies.Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula.Efficacy of leflunomide combined with prednisone in the treatment of refractory nephrotic syndrome.Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.

P2860

Q26747770-62776BCE-FEF5-4134-AC10-46F5690E7708 Q37680867-9A72EB17-4D79-457E-8C44-E102BFB82286 Q38752528-8B8FEA31-5439-45A2-AB3E-F4FE88EBBA82 Q39331611-FDF9B3D0-E55D-41B7-B8AC-9ABDBCA1EF89 Q39573377-A1A66B2F-EEE9-4AE9-9625-3C43767BFEEC Q43805398-3386FC02-96AE-48A1-BDCB-FDBD9F0BCA49 Q49500608-9A18FBEE-5441-4FA7-A6E5-8C9E3FA7EDD8 Q50100678-BCB4B46D-FD9E-4015-B154-2223EA9547CD Q51292313-A9CAE168-606E-4978-A0C5-3D01EE05B2B5 Q51341198-231AFFCC-0B46-4CF9-9023-5CFFBD04439A Q53086368-3B37A65A-D05C-47EC-855B-960A690BE63C

P2860

Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience.

http://www.wikidata.org/entity/Q38191615

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Second-line immunosuppressive ...... e: a single-center experience.

@en

type

label

Second-line immunosuppressive ...... e: a single-center experience.

@en

prefLabel

Second-line immunosuppressive ...... e: a single-center experience.

@en

P1433

Q38191615-4CB0A744-60D9-4307-B378-86AD99336CD3

P1476

Q38191615-2B5EB196-C764-4D48-99C8-09EFA3179AFB

P2093

Q38191615-96F55280-13A0-4391-BD71-555B8B0D5804

Q38191615-C2034096-35E3-4846-9CF3-6B492D6CD337

Q38191615-D0FDEEE7-FEDB-4F68-9136-7D8C54C58B44

Q38191615-D789A381-7EAE-4F11-8187-82AD23EA8EF6

Q38191615-EA765352-5ABF-4F4B-AFA2-A54B933D4614

P2860

Q38191615-00B72A01-7FFD-408E-8CAB-8A8B3E57EE23

Q38191615-08ACEBF2-D1FF-4244-B843-307DCC726B92

Q38191615-1ADFC993-C225-496E-B83C-1A772A90D9F9

Q38191615-38E3E727-0895-4DDD-8979-D8CCF82091EB

Q38191615-46133CF4-347B-4820-A97D-259A9C43F605

Q38191615-5169DF24-866D-4643-9671-7710579CB254

Q38191615-5676144D-9FBE-491B-B451-D5BD8365B83C

Q38191615-6B164FCB-7C79-44AF-A761-D9A803B0C4FD

Q38191615-86B68A5E-05A7-4073-93FB-243D190B87E5

Q38191615-9484D15C-A2CF-49FD-9CE6-82902ACA42C7

P304

Q38191615-DEE291DD-5470-4E76-998C-CBB17D68346D

P31

Q38191615-57773A2F-9844-40FB-8292-9B29F901FD2A

P356

Q38191615-C199823D-1B7E-418E-A940-31FE79D9D707

P433

Q38191615-E0A7E397-BB0D-4B49-B4AB-50D19B23B64E

P478

Q38191615-D5730EBD-36CB-4C0D-8B4D-86FA733F1EEF

P50

Q38191615-4C11E9C5-95CD-4AA5-A550-616EE5CA35A8

P577

Q38191615-DC707F5F-BACE-4AC4-A98D-94A4ABBFA25F

P5875

Q38191615-89E6FD85-6EB1-42EF-9CBC-D9E20CCDFC2D

P698

Q38191615-1C9DB739-0E8F-41EC-BED9-819B331BC3D3

P932

Q38191615-BC1DEF6C-2282-4A68-9B4F-AB46F2A0E997

P356

P1433

P1476

Second-line immunosuppressive ...... e: a single-center experience.

@en

P2093

C Sethna

http://www.w3.org/2001/XMLSchema#string

L Infante

http://www.w3.org/2001/XMLSchema#string

N Chorny

http://www.w3.org/2001/XMLSchema#string

N Patnaik

http://www.w3.org/2001/XMLSchema#string

R Frank

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.

Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure.

Nephrotic syndrome in childhood.

Primary focal segmental glomerular sclerosis in children: clinical course and prognosis.

Experience with tacrolimus in children with steroid-resistant nephrotic syndrome.

New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.

Proteinuria and progression in human glomerular diseases.

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.

Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus.

P304

8-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000357355

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260397225

http://www.w3.org/2001/XMLSchema#string

P698

24575119

http://www.w3.org/2001/XMLSchema#string

P932

3934602

http://www.w3.org/2001/XMLSchema#string